Unknown

Dataset Information

0

Determination of Mutational Timing of Colistin-Resistance Genes through Klebsiella pneumoniae Evolution.


ABSTRACT: The emergence and dissemination of carbapenem-resistant Klebsiella pneumoniae (KP), one of the carbapenem-resistant Enterobacteriaceae (CRE), is now an emerging cause of antibiotic-resistant nosocomial infections associated with high rates of morbidity and mortality. Colistin, or polymyxin E, is a last-resort peptide antibiotic used to treat multidrug-resistant (MDR) Gram-negative bacterial infections including KP. Unfortunately, resistance to colistin is rising with increasing use in the clinical setting. Although clinical evidence links certain mutations to colistin resistance (COL-R) in KP, the origination and association of the mutations remain unclear. We hypothesize that the timing of COL-R mutations influences the development and progression of KP resistance to colistin. We performed planktonic and biofilm in vitro experimental evolutions of KP strain ATCC 43816 under increasing colistin concentrations to characterize the temporal regulation of critical COL-R mutations throughout COL-R progression. The resistance generation and mutation profiles of independently evolved bacterial populations with different lifestyles were compared. Genes with various functions theorize the timeline in which key mutations are generated and their roles in the progression of COL-R. Our results aim to advance the research and development of effective therapeutics to treat MDR bacterial infection as the dissemination of CRE continues to be a severe public health threat.

SUBMITTER: Kuhn JM 

PROVIDER: S-EPMC9862994 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Determination of Mutational Timing of Colistin-Resistance Genes through <i>Klebsiella pneumoniae</i> Evolution.

Kuhn Jenna M JM   Di Yuanpu Peter YP  

Pharmaceutics 20230112 1


The emergence and dissemination of carbapenem-resistant <i>Klebsiella pneumoniae</i> (KP), one of the carbapenem-resistant <i>Enterobacteriaceae</i> (CRE), is now an emerging cause of antibiotic-resistant nosocomial infections associated with high rates of morbidity and mortality. Colistin, or polymyxin E, is a last-resort peptide antibiotic used to treat multidrug-resistant (MDR) Gram-negative bacterial infections including KP. Unfortunately, resistance to colistin is rising with increasing use  ...[more]

Similar Datasets

| S-EPMC11217424 | biostudies-literature
| S-EPMC4394772 | biostudies-literature
| S-EPMC4879426 | biostudies-literature
| S-EPMC8293170 | biostudies-literature
| S-EPMC5403025 | biostudies-literature
2014-08-08 | E-ERAD-246 | biostudies-arrayexpress
| S-EPMC5961088 | biostudies-literature
2022-11-07 | GSE217148 | GEO
| S-EPMC4136067 | biostudies-literature